2025-03-21 apnews
Beijing Shangfang Smart Clean Energy Co., Ltd. is positioned as a full-process clean energy asset development and management platform (DEPCO). The company has launched its new brand "Emperor Guangwu," focusing on residential and commercial/industrial rooftop photovoltaic systems, energy storage, and smart integrated energy solutions. Rooted in technological innovation and leveraging platform advantages, GWD Energy is committed to "building a world-class clean energy asset development and management platform," advancing China's zero-carbon society, actively addressing global climate change, and fostering a global green energy future.

The company boasts state-owned enterprise backing, with its headquarters in Beijing and its group located in Hengqin, Zhuhai. One of its shareholders is Huafa Group, a large state-owned enterprise established in 1980. Huafa Group is Zhuhai’s largest comprehensive state-owned enterprise group, a nationally renowned leader, a pioneer in China’s new energy sector, and ranked among China’s Top 500 Enterprises. Additionally, the company’s shareholders include top international investment institutions, with managed assets totaling approximately CNY 200 billion.
Dr. Jin Xin, General Manager of the company, holds a Ph.D. in photovoltaic and new energy materials from the world-renowned Debye Institute for Nanomaterials Science at Utrecht University in the Netherlands. The core team comprises China’s first generation of solar photovoltaic experts, with over 10GW of photovoltaic project development and construction experience.
Company: GWD Energy GmbH
Contact: Zhou Chun
Email: zhouchun@gwdenergy.com
Website: www.gwdenergy.de
Tel: +86 4001381818
City: Beijing
CGTN: How China embraces the world with open arms, boosts development for all
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
©copyright 2009-2020 Singapore Info Map